MedTrace Logo

Effect of Caudal Nalbuphine on Postoperative Analgesia in Children

NCT02618876 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-04-07

No results posted yet for this study

Summary

Nalbuphine as an adjuvant to bupivacaine caudal anesthesia for postoperative analgesia in children undergoing Hypospadias repair.

2 groups, 30 patients each

Conditions

  • Postoperative Pain

Interventions

DRUG

Nalbuphine plus Bupivacaine

Addition of caudal Nalbuphine to the standard Bupivacaine

DRUG

Bupivacaine

Caudal Bupivacaine is the standard of care will be considered as a control

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
10 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02618876 on ClinicalTrials.gov